文献速递胸部CT

石棉暴露人群的低剂量胸部计算机断层扫描筛查

Low-dose chest computed tomography screening of subjects exposed to asbestos.
PubMed 文献 · Eur J Radiol · 2018-02-16

这项前瞻性多中心横断面研究纳入2010至2012年间2132名有石棉暴露史者,采用低剂量CT筛查肺癌和恶性胸膜间皮瘤。肺癌病理确诊45例(2.1%),恶性胸膜间皮瘤7例(0.3%);吸烟史、纤维化合并肺气肿改变及胸腔积液与肺癌患病率相关。

要点

  • 石棉暴露人群中胸膜斑最常见(89.4%),肺气肿改变占46.0%,纤维化改变占26.5%。
  • 肺癌病理确诊率2.1%,恶性胸膜间皮瘤0.3%;有吸烟史者肺癌患病率2.5%,显著高于从不吸烟者的0.7%。
  • 纤维化合并肺气肿改变者肺癌患病率4.0%,显著高于两者均无者的1.8%。

核心结论

  • 吸烟史、纤维化合并肺气肿改变及胸腔积液与肺癌患病率相关。

研究设计与样本

  • 前瞻性多中心横断面研究,纳入2010至2012年间2132名有石棉暴露史者,采用低剂量CT筛查,CT剂量指数为2.7 mGy。

关键影像表现/征象

  • 胸膜斑在大多数受检者中检出(89.4%),肺气肿改变见于46.0%。
  • 纤维化改变检出565例(26.5%)。
  • 评估的CT表现包括胸膜下弧线影/胸膜下点状影、磨玻璃影或小叶间隔网状影、牵拉性支气管扩张、蜂窝状改变、肺实质带、肺气肿改变、胸腔积液、弥漫性胸膜增厚、圆形肺不张、胸膜斑及肿瘤形成。

诊断标准与关键数值

  • 肺癌病理确诊45例(2.1%),恶性胸膜间皮瘤确诊7例(0.3%)。
  • 有吸烟史者肺癌患病率2.5%,从不吸烟者0.7%,差异有统计学意义(p=0.027)。
  • 有肺气肿改变者肺癌患病率2.8%,无肺气肿改变者1.6%,差异未达统计学显著(p=0.056)。
  • 纤维化合并肺气肿改变者肺癌患病率4.0%,两者均无者1.8%,差异有统计学意义(p=0.011)。

临床应用与阅片要点

  • logistic回归分析显示吸烟史、纤维化合并肺气肿改变及胸腔积液为显著解释变量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The primary aim was to reveal the prevalence of lung cancer (LC) and malignant pleural mesothelioma (MPM) in subjects with past asbestos exposure (AE). We also examined pulmonary or pleural changes correlated with the development of LC.

MATERIALS AND METHODS: This was a prospective, multicenter, cross-sectional study. There were 2132 subjects enrolled between 2010 and 2012. They included 96.2% men and 3.8% women, with a mean age of 76.1 years; 78.8% former or current smokers; and 21.2% never smokers. We screened subjects using low-dose computed tomography (CT). The CT images were taken with a CT dose Index of 2.7 mGy. The evaluated CT findings included subpleural curvilinear shadow/subpleural dots, ground glass opacity or interlobular reticular opacity, traction bronchiectasia, honeycombing change, parenchymal band, emphysema changes, pleural effusion, diffuse pleural thickening, rounded atelectasis, pleural plaques (PQs), and tumor formation.

RESULTS: The PQs were detected in most of subjects (89.4%) and emphysema changes were seen in 46.0%. Fibrotic changes were detected in 565 cases (26.5%). A pathological diagnosis of LC was confirmed in 45 cases (2.1%) and MPM was confirmed in 7 cases (0.3%). The prevalence of LC was 2.5% in patients with a smoking history, which was significantly higher than that in never smokers (0.7%, p = 0.027). The prevalence of LC was 2.8% in subjects with emphysema changes, which was higher than that of subjects without those findings (1.6%); although, the difference was not statistically significant (p = 0.056). The prevalence of LC in subjects with both fibrotic plus emphysema changes was 4.0%, which was significantly higher than that of subjects with neither of those findings (1.8%, p = 0.011). Logistic regression analysis revealed smoking history, fibrotic plus emphysema changes, and pleural effusion as significant explanatory variables.

CONCLUSIONS: Smoking history, fibrotic plus emphysema changes, and pleural effusion were correlated with the prevalence of LC.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Kato K, Gemba K, Ashizawa K, et al. Low-dose chest computed tomography screening of subjects exposed to asbestos. Eur J Radiol. 2018. PMID: 29571785. doi:10.1016/j.ejrad.2018.02.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。